Condition: Venous Stasis Ulcer · Venous Leg Ulcer · Sponsor: Merakris Therapeutics
DL-VSU-201 is a randomized, double-blind, placebo-controlled study in subjects with a non-infected venous stasis ulcer (VSU) that has failed to demonstrate improvement after receiving at least 4 weeks of standard, conventional wound therapy to evaluate the efficacy and safety of MTX-001.
This description comes directly from the study's public registry record.
T Che Jarrell, MBA · 919-921-8105 · medaffairs@merakris.com
Always discuss trial participation with your own doctor first.
| Site 02 | Tucson, Arizona, United States | Recruiting |
| Site 9C | Castro Valley, California, United States | Recruiting |
| Site 03 | Fresno, California, United States | Recruiting |
| Site 9A | San Francisco, California, United States | Recruiting |
| Site 9B | San Francisco, California, United States | Recruiting |
| Site 12 | Vista, California, United States | Recruiting |
| Site 13 | Tampa, Florida, United States | Recruiting |
| Site 14 | Opelousas, Louisiana, United States | Recruiting |
| Site 04 | New Hyde Park, New York, United States | Recruiting |
| Site 08 | Circleville, Ohio, United States | Recruiting |
| Site 01 | Salem, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04647240